lost weight on semaglutide but not tirzepatide vs. Semaglutide: Key Differences & Benefits People taking GLP-1 weight loss

Zepbound and Mounjaro are GLP-1s and they also positively affect glucose-dependent insulinotropic polypeptide (GIP) receptors, making them dual agonist medications

Weight loss Clinical trials show an average 15 to 22% reduction in body weight, outperforming semaglutides 10 to 15%

Posted by Brennan Manna DiamondClient Alert Supreme Court Clears Path for TPS Terminations: What Employers Need to Know June 25, 2026The U.S

You may value body acceptance and reject diet cultureand still find yourself drawn to a GLP-1 because it promises relief, stability, or control

Gastrointestinal AEs in all groups were 43.5% and 39.9% in the 0.5- and 1-mg semaglutide groups, respectively, and 23.6% in the sitagliptin group

Research suggests that the mechanisms behind their effects are independent of one another and potentially additive